World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
Russia
2026

D-Index & Metrics

Biology and Biochemistry

D-Index
81
Citations
45033
World Ranking
3789
National Ranking
2

Research.com Recognitions

  • 2026 - Research.com Biology and Biochemistry in Russia Leader Award
  • 2025 - Research.com Biology and Biochemistry in Russia Leader Award

Overview

Victor Koteliansky is affiliated with the Skolkovo Institute of Science and Technology in the Russian Federation. Their research contributions primarily span the fields of biochemistry, genetics, and molecular biology, with a total of 14 publications. Within these domains, their work covers several subfields including molecular biology, cell biology, cancer research, cardiology and cardiovascular medicine, and epidemiology.

The scientist's research addresses multiple specialized topics, reflecting a focus on molecular and cellular processes. These topics include:

  • RNA modifications and cancer
  • RNA research and splicing
  • Cellular mechanics and interactions
  • Hippo pathway signaling and YAP/TAZ
  • Cancer-related molecular mechanisms research
  • Microtubule and mitosis dynamics
  • RNA and protein synthesis mechanisms

Victor Koteliansky has coauthored several publications with frequent collaborators. Notable coauthors include Timofei S. Zatsepin, Roman L. Bogorad, Daniel G. Anderson, Lenka Belicová, and Urška Repnik, with collaboration counts ranging from two to four publications each.

Their work has been published in various scientific venues, reflecting interdisciplinary engagement. These venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Cell Biology
  • Scientific Reports
  • Molecular Therapy - Methods & Clinical Development
  • Cell Death and Disease

Among their recent papers are:

  • "Anisotropic expansion of hepatocyte lumina enforced by apical bulkheads," 2021, The Journal of Cell Biology
  • "Translation elongation factor 2 depletion by siRNA in mouse liver leads to mTOR-independent translational upregulation of ribosomal protein genes," 2020, Scientific Reports
  • "Liver-Specific siRNA-Mediated Stat3 or C3 Knockdown Improves the Outcome of Experimental Autoimmune Myocarditis," 2020, Molecular Therapy - Methods & Clinical Development
  • "Identification of a long non-coding RNA regulator of liver carcinoma cell survival," 2021, Cell Death and Disease
  • "Identification of a long non-coding RNA regulator of liver carcinoma cell survival," 2020, bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

    Jürgen Soutschek;Akin Akinc;Birgit Bramlage;Klaus Charisse

  • MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

    Thomas Thum;Carina Gross;Jan Fiedler;Thomas Fischer

  • Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter

    Joshua M. Baughman;Fabiana Perocchi;Fabiana Perocchi;Hany S. Girgis;Hany S. Girgis;Molly Plovanich;Molly Plovanich

  • RNAi-mediated gene silencing in non-human primates

    Tracy S. Zimmermann;Amy C. H. Lee;Akin Akinc;Birgit Bramlage

  • A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

    Akin Akinc;Andreas Zumbuehl;Andreas Zumbuehl;Michael Goldberg;Elizaveta S Leshchiner

  • Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape

    Jerome Gilleron;William Querbes;Anja Zeigerer;Anna Borodovsky

  • RNAi therapeutics: a potential new class of pharmaceutical drugs.

    David Bumcrot;Muthiah Manoharan;Victor Koteliansky;Dinah W Y Sah

  • From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus

    Kiran Musunuru;Kiran Musunuru;Kiran Musunuru;Alanna Strong;Maria Frank-Kamenetsky;Noemi E. Lee

  • Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms.

    Akin Akinc;William Querbes;Soma De;June Qin

  • Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1

    Chun Geun Lee;Robert J. Homer;Zhou Zhu;Sophie Lanone

  • Lipid-like materials for low-dose, in vivo gene silencing

    Kevin T. Love;Kerry P. Mahon;Christopher G. Levins;Kathryn A. Whitehead

  • Mechanisms and optimization of in vivo delivery of lipophilic siRNAs

    Christian Wolfrum;Shuanping Shi;K Narayanannair Jayaprakash;Muthusamy Jayaraman

  • Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype

    Hao Yin;Wen Xue;Sidi Chen;Roman L Bogorad

  • Therapeutic siRNA silencing in inflammatory monocytes in mice

    Florian Leuschner;Partha Dutta;Rostic Gorbatov;Tatiana I Novobrantseva

  • Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo

    Hao Yin;Chun-Qing Song;Joseph R. Dorkin;Lihua Julie Zhu

  • Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates

    Maria Frank-Kamenetsky;Aldo Grefhorst;Norma N. Anderson;Timothy S. Racie

  • Origins of tumor-associated macrophages and neutrophils

    Virna Cortez-Retamozo;Martin Etzrodt;Andita Newton;Philipp J. Rauch

  • In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight

    James E. Dahlman;Carmen Barnes;Omar F. Khan;Aude Thiriot

  • Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases

    Rebecca S. Muraoka;Nancy Dumont;Christoph A. Ritter;Teresa C. Dugger

  • TGF-β is a critical mediator of acute lung injury

    Jean-Francois Pittet;Mark J.D. Griffiths;Tom Geiser;Naftali Kaminski

Frequent Co-Authors

Marino Zerial
Marino Zerial Max Planck Society
Muthiah Manoharan
Muthiah Manoharan Alnylam Pharmaceuticals (United States)
Antonin de Fougerolles
Antonin de Fougerolles Alnylam Pharmaceuticals (United States)
Matthias Nahrendorf
Matthias Nahrendorf Harvard University
Wen Xue
Wen Xue University of Massachusetts Chan Medical School
Frank Jülicher
Frank Jülicher Max Planck Society
Markus Stoffel
Markus Stoffel University of Geneva
Laurie H. Glimcher
Laurie H. Glimcher Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology or Biochemistry in the USA opens the door to a diverse range of online degree options and career trajectories, especially within healthcare and life sciences. Many professionals are turning to flexible learning formats to fast-track or specialize in their careers.

For those interested in healthcare leadership, an online masters healthcare management program can provide essential business and organizational skills. Individuals aiming for advanced clinical roles might explore pmhnp programs for Psychiatric Mental Health Nurse Practitioners.

If nutrition and wellness are your focus, a 2 year nutrition degree online is an efficient way to gain expertise for careers in food science, dietetics, or health education. Additionally, management-minded students might consider an affordable online mba in healthcare management to expand their leadership horizons.

These flexible online programs complement a background in Biology or Biochemistry and offer practical pathways to advancement in a competitive health science job market.

Best Scientists Citing Victor Koteliansky

Trending Scientists

Recently Published Articles